<< Part II & III - Therapeutic Groups
Online HML - April 2020
| Nervous System |
|
|
Agents for Parkinsonism and Related Disorders Agents for Essential Tremor, Chorea and Related Disorders; Anticholinergics; Dopamine Agonists and Related Agents |
|
|
Anaesthetics General Anaesthetics; Local Anaesthetics |
|
|
Analgesics Non-Opioid Analgesics; Opioid Analgesics |
|
|
Antidepressants Cyclic and Related Agents; Monoamine-Oxidase Inhibitors - Non-Selective; Monoamine-Oxidase Type A Inhibitors; Other Antidepressants; Selective Serotonin Reuptake Inhibitors |
|
|
Antiepilepsy Drugs Agents for the Control of Status Epilepticus; Control of Epilepsy |
|
|
Antimigraine Preparations Acute Migraine Treatment; Prophylaxis of Migraine |
|
|
Antinausea and Vertigo Agents Antinausea and Vertigo Agents |
|
|
Antipsychotic Agents Depot Injections; General |
|
|
Anxiolytics Anxiolytics |
|
|
Multiple Sclerosis Treatments Multiple Sclerosis Treatments; Other Multiple Sclerosis Treatments |
|
|
Sedatives and Hypnotics Sedatives and Hypnotics |
|
|
Stimulants / ADHD Treatments Stimulants / ADHD Treatments |
|
|
Treatments for Dementia Treatments for Dementia |
|
|
Treatments for Substance Dependence Treatments for Substance Dependence |
